| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | GALNT3 CDHR1 PCDHB5 CDH23 ADGRV1 TBC1D8B FAT2 PLCB1 PLCG1 LTBP4 DNASE1L2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 SLC25A13 LRP1 LRP4 AGRN PCDHGA8 CDH7 CDH12 CDH16 | 2.18e-11 | 749 | 189 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.89e-05 | 120 | 189 | 8 | GO:0008013 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.27e-05 | 70 | 189 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | coreceptor activity | 6.18e-05 | 72 | 189 | 6 | GO:0015026 | |
| GeneOntologyMolecularFunction | protein kinase binding | CENPE CADM4 KIZ GOLGA6A RAD54L2 CCNYL1 PLCG1 NCK2 ANK2 GRK5 TOM1L1 GOLGA6D RFFL CEP192 APP LDB3 ARRB2 LRP4 TRIB1 EP300 FRMD5 | 8.49e-05 | 873 | 189 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | CEBPA CENPE CADM4 KIZ GOLGA6A RAD54L2 CCNYL1 PLCG1 NCK2 ANK2 GRK5 TOM1L1 GOLGA6D RFFL CEP192 APP LDB3 ARRB2 LRP4 TRIB1 EP300 FRMD5 | 1.32e-04 | 969 | 189 | 22 | GO:0019900 |
| GeneOntologyMolecularFunction | chromatin binding | CEBPA ERCC6 RAD21L1 KLF4 NFKB1 ACTL6B TAF5 NONO OGT NELFA TSPY26P APP ADNP SBNO2 SBNO1 EGR2 TRIM37 EP300 | 2.39e-04 | 739 | 189 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.13e-04 | 18 | 189 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 8.45e-04 | 20 | 189 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 8.75e-04 | 5 | 189 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.10e-04 | 118 | 189 | 6 | GO:0003774 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CADM4 CDHR1 PCDHB5 CDH23 PLXNB2 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 NECTIN3 PCDHGA8 CDH7 CDH12 CDH16 | 1.69e-18 | 187 | 185 | 22 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CADM4 CDHR1 PCDHB5 CDH23 KLF4 PLXNB2 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 NECTIN3 TENM4 PCDHGA8 CDH7 CDH12 CDH16 | 8.96e-16 | 313 | 185 | 24 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CADM4 CDHR1 PCDHB5 CDH23 ADGRV1 KLF4 PLXNB2 LILRB1 NEO1 FAT2 ACTL6B NCK2 FAT4 ANK3 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 NECTIN3 PTPRU TENM4 PCDHGA8 CDH7 EP300 CDH12 CDH16 | 2.09e-09 | 1077 | 185 | 32 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.26e-08 | 53 | 185 | 8 | GO:0016339 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | CEBPA ERCC6 CENPE GOLGA6A TNFRSF10C KLF4 PLXNB2 LILRB1 RAB3GAP2 PLCB1 FGFR1 HECTD1 MTCH1 LILRB5 NCK2 OGT NRDC HTRA2 NELFA NOP53 TOM1L1 GOLGA6D TEAD1 APP ADNP ECT2 ARRB2 LRP1 LRP4 PRKDC TNFRSF1A AGRN TRIB1 EP300 | 2.39e-07 | 1458 | 185 | 34 | GO:0051247 |
| GeneOntologyBiologicalProcess | cell junction assembly | PCDHB5 PLXNB2 FGFR1 OGT ANK2 PCDHB6 PCDHB4 PCDHB3 LAMC1 NECTIN3 APP ADNP ECT2 SETD5 LRP1 LRP4 AGRN CDH7 CDH12 | 9.41e-07 | 569 | 185 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | neuron development | ERCC6 KIF26A CDHR1 CDH23 GOLGA6A RDH13 ADGRV1 KLF4 PLXNB2 NEO1 VPS13A ACTL6B FGFR1 MTCH1 NCK2 FAT4 ANK3 NRDC HTRA2 FAT3 GOLGA6D LAMC1 APP ADNP TENM4 EGR2 LRP1 LRP4 GRIP2 AGRN EP300 SOS1 | 2.29e-06 | 1463 | 185 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | synapse assembly | PCDHB5 PLXNB2 FGFR1 OGT PCDHB6 PCDHB4 PCDHB3 NECTIN3 APP ADNP SETD5 LRP4 AGRN | 4.45e-06 | 308 | 185 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | cell junction organization | PCDHB5 PLXNB2 FGFR1 OGT ANK2 ANK3 PCDHGC4 DLGAP4 PCDHB6 PCDHB4 PCDHB3 LAMC1 NECTIN3 APP ADNP ECT2 TENM4 SETD5 LRP1 LRP4 GRIP2 AGRN CDH7 CDH12 | 7.06e-06 | 974 | 185 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DLGAP2 DLGAP1 PCDHB5 ANKS1B LILRB1 NEO1 VPS13A KCNN1 PLCB1 PLCG1 LILRB5 DLGAP4 PCDHB6 PCDHB4 PCDHB3 GRIK5 APP ADNP ARRB2 EGR2 DNAJC5 GRIP2 AGRN | 1.07e-05 | 931 | 185 | 23 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DLGAP2 DLGAP1 PCDHB5 ANKS1B LILRB1 NEO1 VPS13A KCNN1 PLCB1 PLCG1 LILRB5 DLGAP4 PCDHB6 PCDHB4 PCDHB3 GRIK5 APP ADNP ARRB2 EGR2 DNAJC5 GRIP2 AGRN | 1.07e-05 | 931 | 185 | 23 | GO:0007268 |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | ERCC6 CENPE GOLGA6A LILRB1 RAB3GAP2 FGFR1 LILRB5 NCK2 OGT NELFA NOP53 TOM1L1 GOLGA6D TEAD1 APP ADNP ECT2 ARRB2 LRP4 TNFRSF1A AGRN TRIB1 EP300 | 1.19e-05 | 937 | 185 | 23 | GO:0031401 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DLGAP2 DLGAP1 PCDHB5 ANKS1B LILRB1 NEO1 VPS13A KCNN1 PLCB1 PLCG1 LILRB5 DLGAP4 PCDHB6 PCDHB4 PCDHB3 GRIK5 APP ADNP ARRB2 EGR2 DNAJC5 GRIP2 AGRN | 1.23e-05 | 939 | 185 | 23 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | DLGAP2 DLGAP1 PCDHB5 ANKS1B LILRB1 NEO1 VPS13A KCNN1 PLCB1 PLCG1 LILRB5 DLGAP4 PCDHB6 PCDHB4 PCDHB3 GRIK5 APP ADNP ARRB2 EGR2 DNAJC5 GRIP2 AGRN | 2.26e-05 | 976 | 185 | 23 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of protein modification process | ERCC6 CENPE CADM4 GOLGA6A PLXNB2 LILRB1 CCNYL1 RAB3GAP2 PRMT2 FGFR1 LILRB5 NCK2 OGT NELFA NOP53 TOM1L1 GPS1 GOLGA6D TEAD1 APP ADNP TRIM27 ECT2 ARRB2 LRP4 PRKDC TNFRSF1A AGRN TRIB1 EP300 | 2.41e-05 | 1488 | 185 | 30 | GO:0031399 |
| GeneOntologyBiologicalProcess | synapse organization | PCDHB5 PLXNB2 FGFR1 OGT ANK3 PCDHGC4 DLGAP4 PCDHB6 PCDHB4 PCDHB3 NECTIN3 APP ADNP TENM4 SETD5 LRP4 GRIP2 AGRN | 4.71e-05 | 685 | 185 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron maturation | 5.36e-05 | 74 | 185 | 6 | GO:0042551 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 6.21e-05 | 47 | 185 | 5 | GO:0045494 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 6.71e-05 | 77 | 185 | 6 | GO:2000144 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 7.65e-05 | 114 | 185 | 7 | GO:0050772 | |
| GeneOntologyBiologicalProcess | neuron projection development | ERCC6 KIF26A CDH23 GOLGA6A ADGRV1 KLF4 PLXNB2 NEO1 VPS13A ACTL6B FGFR1 NCK2 FAT4 ANK3 NRDC FAT3 GOLGA6D LAMC1 APP ADNP EGR2 LRP1 LRP4 AGRN EP300 SOS1 | 8.45e-05 | 1285 | 185 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | NCF2 NONO PCDHGC4 HTRA2 GRIK5 APP ADNP ARRB2 LRP1 DNAJC5 TNFRSF1A AGRN | 9.12e-05 | 355 | 185 | 12 | GO:0043523 |
| GeneOntologyBiologicalProcess | neuron apoptotic process | NCF2 TNFRSF10C NONO PCDHGC4 HTRA2 GRIK5 APP ADNP ARRB2 LRP1 DNAJC5 TNFRSF1A AGRN | 9.54e-05 | 413 | 185 | 13 | GO:0051402 |
| GeneOntologyBiologicalProcess | synaptic assembly at neuromuscular junction | 1.11e-04 | 11 | 185 | 3 | GO:0051124 | |
| GeneOntologyBiologicalProcess | positive regulation of programmed cell death | NCF2 TNFRSF10C LILRB1 FAP ALDH1A2 PRMT2 PLCG1 MTCH1 NCK2 HTRA2 GRIK5 APP ECT2 ARRB2 PRKDC TNFRSF1A AGRN EP300 | 1.23e-04 | 739 | 185 | 18 | GO:0043068 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CDHR1 CDH23 GOLGA6A PLXNB2 NEO1 ANK3 NRDC FAT3 GOLGA6D LAMC1 APP ADNP EGR2 LRP1 LRP4 AGRN EP300 SOS1 | 1.43e-04 | 748 | 185 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.70e-04 | 91 | 185 | 6 | GO:2000142 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CDHR1 CDH23 GOLGA6A PLXNB2 NEO1 HPS1 VPS13A ANK3 NRDC FAT3 GOLGA6D LAMC1 APP ADNP ECT2 EGR2 LRP1 LRP4 PRKDC AGRN CDH7 EP300 CDH12 SOS1 | 1.79e-04 | 1194 | 185 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 1.87e-04 | 175 | 185 | 8 | GO:0031644 | |
| GeneOntologyBiologicalProcess | axonogenesis | GOLGA6A PLXNB2 NEO1 ANK3 NRDC GOLGA6D LAMC1 APP ADNP EGR2 LRP1 LRP4 AGRN EP300 SOS1 | 1.87e-04 | 566 | 185 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | ERCC6 GALNT3 CADM4 GALNT16 PRMT2 FGFR1 OGT APP ADNP TRIM27 P3H4 ARRB2 EGR2 TTLL4 LRP4 PRKDC MORC3 TNFRSF1A AGRN EP300 SENP7 | 1.88e-04 | 976 | 185 | 21 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | ERCC6 CENPE CADM4 PLXNB2 CCNYL1 PRMT2 FGFR1 NCK2 OGT NOP53 TOM1L1 TEAD1 APP ADNP TRIM27 ECT2 ARRB2 LRP4 PRKDC TNFRSF1A AGRN TRIB1 EP300 | 2.14e-04 | 1133 | 185 | 23 | GO:0001932 |
| GeneOntologyBiologicalProcess | axon development | GOLGA6A KLF4 PLXNB2 NEO1 ANK3 NRDC GOLGA6D LAMC1 APP ADNP EGR2 LRP1 LRP4 AGRN EP300 SOS1 | 2.29e-04 | 642 | 185 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of Rac protein signal transduction | 2.64e-04 | 35 | 185 | 4 | GO:0035020 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process | NCF2 TNFRSF10C LILRB1 FAP ALDH1A2 PRMT2 PLCG1 MTCH1 NCK2 HTRA2 GRIK5 APP ECT2 ARRB2 PRKDC TNFRSF1A AGRN | 2.66e-04 | 718 | 185 | 17 | GO:0043065 |
| GeneOntologyBiologicalProcess | retina homeostasis | 2.73e-04 | 64 | 185 | 5 | GO:0001895 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 2.95e-04 | 36 | 185 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | PLCB1 TCAF2 OGT ANK3 RNF31 HTRA2 APP ECT2 NMD3 LRP1 LRP4 GRIP2 TNFRSF1A AGRN EP300 | 2.97e-04 | 591 | 185 | 15 | GO:1903829 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | DLGAP2 DLGAP1 LILRB1 NEO1 VPS13A PLCB1 PLCG1 LILRB5 DLGAP4 GRIK5 APP ADNP ARRB2 EGR2 GRIP2 AGRN | 3.28e-04 | 663 | 185 | 16 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | DLGAP2 DLGAP1 LILRB1 NEO1 VPS13A PLCB1 PLCG1 LILRB5 DLGAP4 GRIK5 APP ADNP ARRB2 EGR2 GRIP2 AGRN | 3.33e-04 | 664 | 185 | 16 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.50e-04 | 192 | 185 | 8 | GO:0050770 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | CEBPA ALDH1A2 PLCB1 ACTL6B FGFR1 MTCH1 FAT4 ANK3 APP GRIP2 AGRN | 3.68e-04 | 354 | 185 | 11 | GO:0071695 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | CENPE RPLP0P6 KLHL41 GOLGA6A NOP53 GOLGA6D RNF213 CEP192 LDB3 PRKDC TRIM37 EP300 DDX28 | 3.72e-04 | 475 | 185 | 13 | GO:0140694 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 4.15e-04 | 70 | 185 | 5 | GO:0060261 | |
| GeneOntologyBiologicalProcess | neuronal ion channel clustering | 4.40e-04 | 17 | 185 | 3 | GO:0045161 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 4.40e-04 | 17 | 185 | 3 | GO:0098962 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 4.45e-04 | 40 | 185 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | astrocyte activation involved in immune response | 4.74e-04 | 4 | 185 | 2 | GO:0002265 | |
| GeneOntologyBiologicalProcess | regulation of blastocyst development | 4.74e-04 | 4 | 185 | 2 | GO:0120222 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 4.74e-04 | 4 | 185 | 2 | GO:0031161 | |
| GeneOntologyBiologicalProcess | pentose catabolic process | 4.74e-04 | 4 | 185 | 2 | GO:0019323 | |
| GeneOntologyBiologicalProcess | heart development | ALDH1A2 FGFR1 HECTD1 TEAD2 FAT4 ANK2 PCDHA12 TEAD1 LDB3 ARRB2 TENM4 LRRC27 LRP1 PRKDC TNFRSF1A EP300 SOS1 | 4.87e-04 | 757 | 185 | 17 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 4.91e-04 | 202 | 185 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 5.04e-04 | 73 | 185 | 5 | GO:0071300 | |
| GeneOntologyBiologicalProcess | regulation of execution phase of apoptosis | 5.37e-04 | 42 | 185 | 4 | GO:1900117 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor clustering | 6.19e-04 | 19 | 185 | 3 | GO:1903911 | |
| GeneOntologyBiologicalProcess | developmental maturation | CEBPA ALDH1A2 PLCB1 ACTL6B FGFR1 MTCH1 FAT4 ANK3 DLGAP4 APP GRIP2 AGRN | 6.32e-04 | 439 | 185 | 12 | GO:0021700 |
| GeneOntologyBiologicalProcess | protein localization to membrane | KCNB2 RAB3GAP2 HECTD1 MTCH1 TCAF2 OGT ANK2 ANK3 GRIK5 NECTIN3 LRP1 LRP4 GRIP2 TNFRSF1A KIF13A AGRN | 6.38e-04 | 705 | 185 | 16 | GO:0072657 |
| GeneOntologyBiologicalProcess | macrophage differentiation | 6.44e-04 | 77 | 185 | 5 | GO:0030225 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | ERCC6 CENPE CADM4 PLXNB2 CCNYL1 PRMT2 FGFR1 NCK2 OGT NOP53 TOM1L1 TEAD1 APP ADNP TRIM27 ECT2 ARRB2 LRP4 PRKDC TNFRSF1A AGRN TRIB1 EP300 | 6.47e-04 | 1226 | 185 | 23 | GO:0042325 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MED18 CEBPA ERCC6 RAD54L2 KLF4 LILRB1 BMP3 NFKB1 FGFR1 TAF5 TAF13 NCK2 TEAD2 OGT NELFA TEAD1 TEAD3 APP ZNF593 SBNO2 EGR2 PRKDC TNFRSF1A AGRN EP300 | 6.87e-04 | 1390 | 185 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | cell maturation | 7.08e-04 | 267 | 185 | 9 | GO:0048469 | |
| GeneOntologyBiologicalProcess | lateral mesoderm development | 7.23e-04 | 20 | 185 | 3 | GO:0048368 | |
| GeneOntologyBiologicalProcess | positive regulation of execution phase of apoptosis | 7.23e-04 | 20 | 185 | 3 | GO:1900119 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 7.86e-04 | 5 | 185 | 2 | GO:0048496 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 8.12e-04 | 81 | 185 | 5 | GO:0060260 | |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis | CEBPA TNFRSF10C HECTD1 MTCH1 OGT NRDC HTRA2 NOP53 APP TRIB1 EP300 | 8.22e-04 | 390 | 185 | 11 | GO:0045862 |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-12 production | 8.38e-04 | 21 | 185 | 3 | GO:0032695 | |
| GeneOntologyBiologicalProcess | regulation of cell development | CEBPA GOLGA6A PLXNB2 LILRB1 PLCB1 ACTL6B LILRB5 NRDC GOLGA6D ADNP ARRB2 TENM4 EGR2 LRP1 LRP4 GRIP2 PRKDC TNFRSF1A TRIB1 EP300 SOS1 | 8.50e-04 | 1095 | 185 | 21 | GO:0060284 |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 9.32e-04 | 125 | 185 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | ERCC6 CENPE CADM4 PLXNB2 LILRB1 CCNYL1 PRMT2 FGFR1 LILRB5 NCK2 OGT NOP53 TOM1L1 TEAD1 APP ADNP TRIM27 ECT2 ARRB2 LRP4 PRKDC TNFRSF1A AGRN TRIB1 EP300 | 9.41e-04 | 1421 | 185 | 25 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | ERCC6 CENPE CADM4 PLXNB2 LILRB1 CCNYL1 PRMT2 FGFR1 LILRB5 NCK2 OGT NOP53 TOM1L1 TEAD1 APP ADNP TRIM27 ECT2 ARRB2 LRP4 PRKDC TNFRSF1A AGRN TRIB1 EP300 | 9.60e-04 | 1423 | 185 | 25 | GO:0051174 |
| GeneOntologyBiologicalProcess | protein homooligomerization | 9.64e-04 | 224 | 185 | 8 | GO:0051260 | |
| GeneOntologyBiologicalProcess | regulation of system process | DLGAP2 DLGAP1 KCNB2 KLF4 FGFR1 ANK2 NRDC DLGAP4 TEAD1 APP TENM4 EGR2 GRIP2 TNFRSF1A AGRN EP300 | 9.77e-04 | 734 | 185 | 16 | GO:0044057 |
| GeneOntologyCellularComponent | TEAD-YAP complex | 2.45e-04 | 3 | 190 | 2 | GO:0140552 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DLGAP2 ANKS1B GOLGA6A VPS16 KCNB2 NEO1 VPS13A KCNN1 USH2A OGT ANK3 NRDC FAT3 DLGAP4 GOLGA6D GRIK5 NECTIN3 APP ADNP ARRB2 LRP1 LRP4 GRIP2 SOS1 | 3.33e-04 | 1228 | 190 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | cell-cell junction | CADM4 PCDHB5 FAT2 PLCG1 ANK2 ANK3 PCDHA12 NECTIN3 PTPRU APP ECT2 LDB3 CDH7 CDH12 FRMD5 | 3.44e-04 | 591 | 190 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | asymmetric synapse | DLGAP2 DLGAP1 ANKS1B NEO1 NCK2 OGT ANK2 ANK3 GRIK5 NECTIN3 LRP1 LRP4 GRIP2 | 4.41e-04 | 477 | 190 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | USH2 complex | 4.87e-04 | 4 | 190 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.61e-04 | 112 | 190 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | postsynaptic specialization | DLGAP2 DLGAP1 ANKS1B NEO1 NCK2 ANK2 ANK3 DLGAP4 GRIK5 NECTIN3 LRP1 LRP4 GRIP2 | 7.23e-04 | 503 | 190 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | DLGAP2 DLGAP1 ANKS1B NEO1 NCK2 ANK2 ANK3 GRIK5 NECTIN3 LRP1 LRP4 GRIP2 | 8.99e-04 | 451 | 190 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | postsynapse | DLGAP2 DLGAP1 ANKS1B NEO1 PLCB1 FGFR1 NCK2 OGT ANK2 ANK3 DLGAP4 GRIK5 NECTIN3 APP KPTN ARRB2 LRP1 LRP4 GRIP2 SENP7 | 1.00e-03 | 1018 | 190 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.02e-03 | 49 | 190 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | DLGAP2 DLGAP1 ANKS1B NEO1 NCK2 OGT ANK2 ANK3 GRIK5 NECTIN3 LRP1 LRP4 GRIP2 | 1.03e-03 | 523 | 190 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.20e-03 | 6 | 190 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.20e-03 | 6 | 190 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.20e-03 | 6 | 190 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.20e-03 | 6 | 190 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.47e-03 | 25 | 190 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | neuronal cell body | GOLGA6A VPS16 KCNB2 NEO1 VPS13A KCNN1 USH2A OGT DLGAP4 GOLGA6D GRIK5 APP ADNP LRP1 LRP4 GRIP2 SOS1 | 1.65e-03 | 835 | 190 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 1.68e-03 | 56 | 190 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 1.68e-03 | 94 | 190 | 5 | GO:0032580 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.68e-03 | 94 | 190 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 2.22e-03 | 8 | 190 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | proteasome regulatory particle, lid subcomplex | 2.22e-03 | 8 | 190 | 2 | GO:0008541 | |
| Domain | Cadherin_CS | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 2.21e-18 | 109 | 191 | 19 | IPR020894 |
| Domain | CADHERIN_1 | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 4.51e-18 | 113 | 191 | 19 | PS00232 |
| Domain | Cadherin | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 4.51e-18 | 113 | 191 | 19 | PF00028 |
| Domain | CADHERIN_2 | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 5.37e-18 | 114 | 191 | 19 | PS50268 |
| Domain | - | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 5.37e-18 | 114 | 191 | 19 | 2.60.40.60 |
| Domain | CA | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 6.37e-18 | 115 | 191 | 19 | SM00112 |
| Domain | Cadherin-like | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 7.55e-18 | 116 | 191 | 19 | IPR015919 |
| Domain | Cadherin | CDHR1 PCDHB5 CDH23 FAT2 FAT4 PCDHGC4 PCDHGB6 FAT3 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 CDH7 CDH12 CDH16 | 1.06e-17 | 118 | 191 | 19 | IPR002126 |
| Domain | Cadherin_2 | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 5.30e-11 | 65 | 191 | 11 | PF08266 |
| Domain | Cadherin_N | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 5.30e-11 | 65 | 191 | 11 | IPR013164 |
| Domain | Cadherin_C | 2.09e-07 | 42 | 191 | 7 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.09e-07 | 42 | 191 | 7 | PF16492 | |
| Domain | Cadherin_tail | 1.89e-06 | 37 | 191 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 1.89e-06 | 37 | 191 | 6 | IPR031904 | |
| Domain | TEA_1 | 4.18e-06 | 4 | 191 | 3 | PS00554 | |
| Domain | TEA_2 | 4.18e-06 | 4 | 191 | 3 | PS51088 | |
| Domain | TEA | 4.18e-06 | 4 | 191 | 3 | PF01285 | |
| Domain | TEA/ATTS_dom | 4.18e-06 | 4 | 191 | 3 | IPR000818 | |
| Domain | TEF_metazoa | 4.18e-06 | 4 | 191 | 3 | IPR016361 | |
| Domain | LRRC37AB_C | 4.18e-06 | 4 | 191 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 4.18e-06 | 4 | 191 | 3 | PF14914 | |
| Domain | TEA | 4.18e-06 | 4 | 191 | 3 | SM00426 | |
| Domain | LRRC37_N | 4.18e-06 | 4 | 191 | 3 | IPR032754 | |
| Domain | LRRC37 | 4.18e-06 | 4 | 191 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 4.18e-06 | 4 | 191 | 3 | IPR015753 | |
| Domain | SAPAP | 1.04e-05 | 5 | 191 | 3 | IPR005026 | |
| Domain | GKAP | 1.04e-05 | 5 | 191 | 3 | PF03359 | |
| Domain | Death | 2.00e-05 | 33 | 191 | 5 | PF00531 | |
| Domain | Death_domain | 4.05e-05 | 38 | 191 | 5 | IPR000488 | |
| Domain | DEATH_DOMAIN | 4.05e-05 | 38 | 191 | 5 | PS50017 | |
| Domain | LAM_G_DOMAIN | 4.05e-05 | 38 | 191 | 5 | PS50025 | |
| Domain | LamG | 8.34e-05 | 44 | 191 | 5 | SM00282 | |
| Domain | SNO | 1.04e-04 | 2 | 191 | 2 | IPR026741 | |
| Domain | SBNO_Helicase_C_dom | 1.04e-04 | 2 | 191 | 2 | IPR026937 | |
| Domain | Helicase_C_4 | 1.04e-04 | 2 | 191 | 2 | PF13871 | |
| Domain | DEATH | 1.55e-04 | 27 | 191 | 4 | SM00005 | |
| Domain | EGF_CA | 2.61e-04 | 122 | 191 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.88e-04 | 124 | 191 | 7 | IPR001881 | |
| Domain | EGF_1 | 3.05e-04 | 255 | 191 | 10 | PS00022 | |
| Domain | Laminin_G | 3.13e-04 | 58 | 191 | 5 | IPR001791 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.53e-04 | 14 | 191 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.53e-04 | 14 | 191 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.53e-04 | 14 | 191 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.53e-04 | 14 | 191 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.53e-04 | 14 | 191 | 3 | IPR011704 | |
| Domain | MT | 3.53e-04 | 14 | 191 | 3 | PF12777 | |
| Domain | AAA_8 | 3.53e-04 | 14 | 191 | 3 | PF12780 | |
| Domain | AAA_5 | 3.53e-04 | 14 | 191 | 3 | PF07728 | |
| Domain | - | 4.32e-04 | 95 | 191 | 6 | 2.60.120.200 | |
| Domain | ConA-like_dom | 4.34e-04 | 219 | 191 | 9 | IPR013320 | |
| Domain | DHC_fam | 4.38e-04 | 15 | 191 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 4.38e-04 | 15 | 191 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.38e-04 | 15 | 191 | 3 | IPR004273 | |
| Domain | DEATH-like_dom | 5.39e-04 | 99 | 191 | 6 | IPR011029 | |
| Domain | - | 6.59e-04 | 39 | 191 | 4 | 2.120.10.30 | |
| Domain | EGF | 7.21e-04 | 235 | 191 | 9 | SM00181 | |
| Domain | Laminin_G_2 | 7.26e-04 | 40 | 191 | 4 | PF02210 | |
| Domain | DDE_Tnp_1_7 | 1.02e-03 | 5 | 191 | 2 | PF13843 | |
| Domain | PGBD | 1.02e-03 | 5 | 191 | 2 | IPR029526 | |
| Domain | EGF-like_dom | 1.08e-03 | 249 | 191 | 9 | IPR000742 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.24e-03 | 46 | 191 | 4 | IPR011042 | |
| Domain | EGF-like_CS | 1.50e-03 | 261 | 191 | 9 | IPR013032 | |
| Domain | EGF_2 | 1.67e-03 | 265 | 191 | 9 | PS01186 | |
| Domain | EGF_CA | 1.89e-03 | 86 | 191 | 5 | PF07645 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 3.71e-06 | 98 | 132 | 8 | M39830 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 1.57e-05 | 6 | 132 | 3 | MM15544 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 4.34e-05 | 8 | 132 | 3 | MM14816 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 4.34e-05 | 8 | 132 | 3 | M27823 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 7.69e-05 | 76 | 132 | 6 | MM15520 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | RGMB COL6A5 PSMD12 ADGRV1 NEO1 FGFR1 PLCG1 NCK2 ANK2 ANK3 LAMC1 TEAD1 EGR2 PSMD14 AGRN SOS1 | 9.34e-05 | 575 | 132 | 16 | M29853 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.34e-04 | 84 | 132 | 6 | M1008 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.40e-04 | 121 | 132 | 7 | M39823 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 1.45e-04 | 29 | 132 | 4 | M29808 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB5 FAT2 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 6.94e-15 | 72 | 193 | 12 | 10380929 |
| Pubmed | PCDHB5 FAT2 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 1.62e-14 | 77 | 193 | 12 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB5 FAT2 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 2.62e-14 | 80 | 193 | 12 | 10716726 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 1.34e-13 | 68 | 193 | 11 | 11230163 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 3.56e-13 | 74 | 193 | 11 | 10817752 |
| Pubmed | DLGAP2 DLGAP1 KCNB2 VPS13A KCNN1 PLCG1 GNS DNASE1L2 ANK2 DLGAP4 PCDHA12 PCDHA11 PCDHA3 ADNP ECT2 GRIP2 KIF13A SOS1 | 4.94e-13 | 329 | 193 | 18 | 17474147 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.02e-09 | 57 | 193 | 8 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.18e-09 | 58 | 193 | 8 | 30377227 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KIF26A KLF4 PLXNB2 RRP12 C19orf44 FGFR1 PLCG1 HECTD1 LTBP4 NCK2 TEAD2 B4GALNT4 GRK5 CEP192 SBNO2 GAREM2 SETD5 TTLL4 LRP4 PRKDC AGRN TRIB1 EP300 CYB5R2 | 1.37e-08 | 1105 | 193 | 24 | 35748872 |
| Pubmed | 1.43e-08 | 15 | 193 | 5 | 20205790 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CENPE RAD21L1 CDH23 PNMA8B DNAH6 DNAH9 ANK3 NOP53 ZNF593 ECT2 RBM39 PHF3 ELAVL3 PRKDC | 1.73e-08 | 361 | 193 | 14 | 26167880 |
| Pubmed | 7.24e-08 | 20 | 193 | 5 | 11322959 | ||
| Pubmed | TRIML1 ERCC6 ACTL6B XYLB TAF5 TAF13 LTBP4 OGT RNF31 FAT3 RNF213 APP TRIM27 P3H4 SETD5 SLC25A13 SAP30BP LRP1 LRP4 EP300 CDH16 SENP7 SOS1 | 7.24e-08 | 1116 | 193 | 23 | 31753913 | |
| Pubmed | 1.13e-07 | 9 | 193 | 4 | 23986861 | ||
| Pubmed | ANKS1B GOLGA6A RAD54L2 KLF4 VPS13A FGFR1 DTHD1 DNAH6 NONO ANK2 PCDHGC4 PCDHGB6 GRK5 GPS1 DNAH2 GOLGA6D SBNO1 SETD5 SLC25A13 SAP30BP DNAJC5 CFAP74 PRKDC ZBTB11 PCDHGA8 ATP5F1A | 1.33e-07 | 1442 | 193 | 26 | 35575683 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 36494579 | ||
| Pubmed | 1.95e-07 | 24 | 193 | 5 | 24698270 | ||
| Pubmed | 6.32e-07 | 13 | 193 | 4 | 12231349 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | DLGAP2 DLGAP1 KIAA0232 RAD54L2 KCNN1 PRMT2 NONO LTBP4 DLGAP4 GPS1 LAMC1 APP TRIM27 GRIP2 AGRN | 6.40e-07 | 560 | 193 | 15 | 21653829 |
| Pubmed | Comparative expression analysis of TEADs and their splice variants in mouse embryonic stem cells. | 6.70e-07 | 4 | 193 | 3 | 36516960 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 9889009 | ||
| Pubmed | The TEA domain: a novel, highly conserved DNA-binding motif. | 6.70e-07 | 4 | 193 | 3 | 2070413 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 9169843 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 8702974 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 22419166 | ||
| Pubmed | Tead transcription factors differentially regulate cortical development. | 6.70e-07 | 4 | 193 | 3 | 32170161 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 7.93e-07 | 91 | 193 | 7 | 28558017 | |
| Pubmed | DLGAP1 ANKS1B RAD54L2 KCNN1 PRMT2 PLCG1 HECTD1 OGT ANK2 ANK3 APP ZNF34 TARS3 SBNO1 LRP1 LRP4 PRKDC MORC3 ZBTB11 TRIM37 EP300 ATP5F1A SOS1 | 8.51e-07 | 1285 | 193 | 23 | 35914814 | |
| Pubmed | ERCC6 GALNT3 RDH13 KLF4 EMSY RRP12 TAF5 NONO OGT DDX31 NOP53 PCDHB7 APP ZNF593 TRIM27 ECT2 SETD5 PHF3 SLC25A13 SAP30BP GEMIN4 ZBTB11 AGRN ATP5F1A DDX28 | 9.67e-07 | 1497 | 193 | 25 | 31527615 | |
| Pubmed | 9.89e-07 | 94 | 193 | 7 | 32062451 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 9671946 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 19324877 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 22677547 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 10518497 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 15024750 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 21527258 | ||
| Pubmed | TEAD mediates YAP-dependent gene induction and growth control. | 1.67e-06 | 5 | 193 | 3 | 18579750 | |
| Pubmed | 1.72e-06 | 102 | 193 | 7 | 11214970 | ||
| Pubmed | 1.73e-06 | 197 | 193 | 9 | 36604605 | ||
| Pubmed | DLGAP2 DLGAP1 CENPE ANKS1B GOLGA6A EMSY PLCB1 TAF5 OGT ANK2 ANK3 DLGAP4 GOLGA6D GRIK5 ADNP SPHKAP LRP1 ELAVL3 AGRN | 2.02e-06 | 963 | 193 | 19 | 28671696 | |
| Pubmed | 2.07e-06 | 17 | 193 | 4 | 18279309 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | KIAA0232 PSMD12 VPS16 NEO1 ALDH1A2 VPS13A FGFR1 MTCH1 NOP53 DLGAP4 TOM1L1 PCDHA12 RNF213 NECTIN3 ATE1 P3H4 PRKDC TNFRSF1A DCBLD2 CDH16 | 2.14e-06 | 1061 | 193 | 20 | 33845483 |
| Pubmed | EMSY RAB3GAP2 TAF5 NONO OGT ANK3 TEAD1 ADNP PHF3 SLC25A13 SAP30BP PRKDC CTPS1 EP300 | 2.70e-06 | 549 | 193 | 14 | 38280479 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 11358867 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 25995450 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GALNT3 PLXNB2 DMXL1 IGSF10 FAP RRP12 HECTD1 GNS FAT4 GPS1 RNF213 LAMC1 NECTIN3 APP P3H4 LRP1 LRP4 TNFRSF1A AGRN DCBLD2 FRMD5 | 3.79e-06 | 1201 | 193 | 21 | 35696571 |
| Pubmed | CENPE PLXNB2 DMXL1 VPS13A PRMT2 B4GALNT4 ANK2 RNF31 FAT3 GRK5 DLGAP4 TOM1L1 LAMC1 DDI2 PRR22 TEAD1 PTPRU AGRN CDH7 TRIM37 EP300 | 4.52e-06 | 1215 | 193 | 21 | 15146197 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 20058854 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 14736747 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 16059920 | ||
| Pubmed | SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. | 5.79e-06 | 7 | 193 | 3 | 9115257 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 36510132 | ||
| Pubmed | Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. | 5.79e-06 | 7 | 193 | 3 | 16207754 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10527873 | ||
| Pubmed | DLGAP2 DLGAP1 ANKS1B PSMD12 KCNB2 SEPTIN6 NEO1 RAB3GAP2 PLCB1 ACTL6B MTCH1 ANK2 ANK3 DLGAP4 ATE1 APP RBM39 TENM4 SPHKAP PSMD14 | 6.14e-06 | 1139 | 193 | 20 | 36417873 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 9.23e-06 | 8 | 193 | 3 | 19683999 | |
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 9.23e-06 | 8 | 193 | 3 | 9538215 | |
| Pubmed | MED18 RAD54L2 EMSY NONO OGT TRIM27 PHF3 SLC25A13 GEMIN4 MORC3 PSMD14 EP300 | 9.72e-06 | 453 | 193 | 12 | 29656893 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | GOLGA6A TBC1D8B TXNL4A RRP12 TAF5 NONO OGT GRK5 GOLGA6D ZNF593 TRIM27 ARRB2 SLC25A13 SAP30BP ATP5F1A | 9.77e-06 | 701 | 193 | 15 | 30196744 |
| Pubmed | 1.23e-05 | 251 | 193 | 9 | 27507650 | ||
| Pubmed | RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells. | 1.38e-05 | 9 | 193 | 3 | 35688159 | |
| Pubmed | 1.46e-05 | 27 | 193 | 4 | 20336759 | ||
| Pubmed | CENPE PSMD12 NHLRC2 NEO1 RAB3GAP2 HECTD1 NCK2 RNF213 NECTIN3 P3H4 PHF3 TTLL4 DNAJC5 CTPS1 PSMD14 | 1.65e-05 | 733 | 193 | 15 | 34672954 | |
| Pubmed | PSMD12 HECTD1 OGT RNF31 TOM1L1 GPS1 RNF213 LAMC1 DDI2 MORC3 PSMD14 AGRN | 1.76e-05 | 481 | 193 | 12 | 28190767 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | NCF2 PSMD12 SEPTIN6 HPS1 PRMT2 FGFR1 NONO GNS NCK2 OGT TRIM27 RBM39 LDB3 EGR2 TRIM37 | 1.90e-05 | 742 | 193 | 15 | 26871637 |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 1.96e-05 | 10 | 193 | 3 | 24618850 | |
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 23064749 | ||
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 24239741 | ||
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 27777310 | ||
| Pubmed | Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. | 2.25e-05 | 30 | 193 | 4 | 34017080 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ERCC6 CENPE RRP12 ANK3 GPS1 PCDHB6 RBM39 SLC25A13 SAP30BP CTPS1 CDH7 HYDIN | 2.42e-05 | 497 | 193 | 12 | 36774506 |
| Pubmed | 2.69e-05 | 11 | 193 | 3 | 15117958 | ||
| Pubmed | 2.69e-05 | 11 | 193 | 3 | 24052308 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KIZ KIAA0232 ADGRV1 SEPTIN6 XYLB PLCG1 HECTD1 NCK2 OGT ANK3 TOM1L1 RNF213 CEP192 APP RBM39 SBNO2 RIC8B ARRB2 SETD5 LRRC27 LRP1 EP300 | 3.02e-05 | 1489 | 193 | 22 | 28611215 |
| Pubmed | Neuronal clearance of amyloid-β by endocytic receptor LRP1. | 3.06e-05 | 2 | 193 | 2 | 24305823 | |
| Pubmed | Time-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLCγ1. | 3.06e-05 | 2 | 193 | 2 | 26482290 | |
| Pubmed | p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. | 3.06e-05 | 2 | 193 | 2 | 11340085 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 21041302 | ||
| Pubmed | Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. | 3.06e-05 | 2 | 193 | 2 | 22854782 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 22888001 | ||
| Pubmed | C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65. | 3.06e-05 | 2 | 193 | 2 | 18373737 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 12212791 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20156456 | ||
| Pubmed | Clearance of amyloid-beta by circulating lipoprotein receptors. | 3.06e-05 | 2 | 193 | 2 | 17694066 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 23580652 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19200568 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19826638 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 32139119 | ||
| Pubmed | TEAD1 and TEAD3 Play Redundant Roles in the Regulation of Human Epidermal Proliferation. | 3.06e-05 | 2 | 193 | 2 | 32142794 | |
| Pubmed | Structure of the repulsive guidance molecule (RGM)-neogenin signaling hub. | 3.06e-05 | 2 | 193 | 2 | 23744777 | |
| Pubmed | Direct interaction of SOS1 Ras exchange protein with the SH3 domain of phospholipase C-gamma1. | 3.06e-05 | 2 | 193 | 2 | 10913276 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 34638692 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19665973 | ||
| Pubmed | Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. | 3.06e-05 | 2 | 193 | 2 | 36695974 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19516260 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20711222 | ||
| Pubmed | Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta. | 3.06e-05 | 2 | 193 | 2 | 19435805 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 15004329 | ||
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 3.06e-05 | 2 | 193 | 2 | 28653555 | |
| Pubmed | Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. | 3.06e-05 | 2 | 193 | 2 | 22086955 | |
| Interaction | RPL23 interactions | RPLP0P6 PCDHB5 CDH23 C1QTNF7 HECTD1 DNASE1L2 FAT4 RNF31 PCDHGC4 FAT3 PCDHB7 PCDHB6 PCDHB3 PCDHA12 PCDHA11 APP ECT2 RBM39 LRP1 GEMIN4 TRIM37 CDH16 | 9.81e-09 | 540 | 191 | 22 | int:RPL23 |
| Interaction | ZEB2 interactions | 2.98e-07 | 95 | 191 | 9 | int:ZEB2 | |
| Interaction | CBX6 interactions | ERCC6 KIAA0232 CDH23 RRP12 DDX31 PCDHGC4 FAT3 PCDHB3 RNF213 PCDHA3 APP TRIM27 ZBTB11 DDX28 | 5.54e-07 | 283 | 191 | 14 | int:CBX6 |
| Interaction | PCDHB4 interactions | 8.38e-07 | 3 | 191 | 3 | int:PCDHB4 | |
| Interaction | CTNNB1 interactions | DLGAP1 CEBPA KLF4 YOD1 NFKB1 FGFR1 HECTD1 NONO ANK2 ANK3 PTPRU APP ADNP ECT2 RBM39 EGR2 SLC25A13 DNAJC5 PRKDC CDH7 TRIM37 EP300 ATP5F1A CDH12 FRMD5 CDH16 | 3.46e-06 | 1009 | 191 | 26 | int:CTNNB1 |
| Interaction | HSP90AB1 interactions | RPLP0P6 PSMD12 NFKB1 RRP12 VPS13A FGFR1 PLCG1 HECTD1 OGT ANK3 RNF31 GRK5 GPS1 DNAH2 DDI2 ECT2 RBM39 ARRB2 SPHKAP PRKDC PSMD14 AGRN TRIM37 ATP5F1A | 1.41e-05 | 960 | 191 | 24 | int:HSP90AB1 |
| Interaction | PRKCD interactions | NHLRC2 KLF4 PLCB1 MTCH1 TOM1L1 APP LDB3 PRKDC TNFRSF1A EP300 SOS1 | 1.77e-05 | 238 | 191 | 11 | int:PRKCD |
| Interaction | UBE3C interactions | PSMD12 HECTD1 PCDHB3 DDI2 PTPRU APP ECT2 PSMD14 EP300 ATP5F1A | 2.59e-05 | 204 | 191 | 10 | int:UBE3C |
| Interaction | PCDHGA10 interactions | 2.71e-05 | 19 | 191 | 4 | int:PCDHGA10 | |
| Interaction | DLGAP2 interactions | 3.22e-05 | 39 | 191 | 5 | int:DLGAP2 | |
| Interaction | GSN interactions | 3.60e-05 | 212 | 191 | 10 | int:GSN | |
| Interaction | NUP210P1 interactions | 4.64e-05 | 42 | 191 | 5 | int:NUP210P1 | |
| Interaction | PCDHA10 interactions | 5.00e-05 | 22 | 191 | 4 | int:PCDHA10 | |
| Interaction | C2CD4B interactions | 5.84e-05 | 44 | 191 | 5 | int:C2CD4B | |
| Interaction | AR interactions | MED18 CEBPA RPLP0P6 PSMD12 RAD54L2 KLF4 EMSY NFKB1 PLCG1 NONO OGT RNF31 NELFA RNF213 TEAD3 ADNP PHF3 PRKDC MORC3 TNFRSF1A PSMD14 EP300 ATP5F1A | 6.87e-05 | 992 | 191 | 23 | int:AR |
| Interaction | NCOA1 interactions | 7.77e-05 | 146 | 191 | 8 | int:NCOA1 | |
| Interaction | PSMD12 interactions | CEBPA ERCC6 PSMD12 HECTD1 OGT DDI2 PTPRU APP RBM39 DNAJC5 PSMD14 ATP5F1A | 7.93e-05 | 331 | 191 | 12 | int:PSMD12 |
| Interaction | OPA3 interactions | 8.06e-05 | 47 | 191 | 5 | int:OPA3 | |
| Interaction | SHANK3 interactions | DLGAP2 DLGAP1 KIAA0232 ANKS1B CDH23 PLCB1 PRMT2 LTBP4 ANK2 ANK3 DLGAP4 GPS1 APP TRIM27 PSMD14 | 8.10e-05 | 496 | 191 | 15 | int:SHANK3 |
| Interaction | PHGDH interactions | CEBPA NHLRC2 FGFR1 HECTD1 OGT DDI2 APP ADNP ECT2 RBM39 PRKDC EP300 ATP5F1A | 8.21e-05 | 385 | 191 | 13 | int:PHGDH |
| Interaction | SOCS7 interactions | 9.87e-05 | 49 | 191 | 5 | int:SOCS7 | |
| Interaction | FOXD4L6 interactions | 9.87e-05 | 49 | 191 | 5 | int:FOXD4L6 | |
| Cytoband | 5q31 | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 2.65e-12 | 115 | 193 | 11 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 6.54e-08 | 298 | 193 | 11 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHB5 PCDHGC4 PCDHGB6 PCDHB7 PCDHB6 PCDHB4 PCDHB3 PCDHA12 PCDHA11 PCDHA3 PCDHGA8 | 8.54e-13 | 64 | 129 | 11 | 20 |
| GeneFamily | Cadherin related | 9.88e-08 | 17 | 129 | 5 | 24 | |
| GeneFamily | TEA domain transcription factors | 1.41e-06 | 4 | 129 | 3 | 1183 | |
| GeneFamily | Dyneins, axonemal | 2.24e-04 | 17 | 129 | 3 | 536 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 3.00e-04 | 4 | 129 | 2 | 1244 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 4.98e-04 | 5 | 129 | 2 | 1182 | |
| GeneFamily | Low density lipoprotein receptors | 3.74e-03 | 13 | 129 | 2 | 634 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.74e-03 | 13 | 129 | 2 | 1186 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.31e-03 | 46 | 129 | 3 | 622 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN | CENPE KLHL41 TNFRSF10C DMXL1 BMP3 RAB3GAP2 ADNP GEMIN4 PSMD14 TRIM37 | 2.48e-06 | 200 | 193 | 10 | M4994 |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN | 1.85e-05 | 200 | 193 | 9 | M9784 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN | 1.85e-05 | 200 | 193 | 9 | M3091 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.00e-06 | 151 | 190 | 9 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | MED18 CENPE NHLRC2 DMXL1 PNMA8B ALDH1A2 C1QTNF7 NONO RNF213 DDI2 ECT2 RBM39 TENM4 SPHKAP | 2.02e-05 | 409 | 190 | 14 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 2.55e-05 | 172 | 190 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | RGMB COL6A5 KLF4 IGSF10 FAP FGFR1 LTBP4 ANK2 LAMC1 TEAD1 APP ADAMTSL3 LRP1 DCBLD2 | 5.06e-05 | 445 | 190 | 14 | GSM777043_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 6.32e-05 | 150 | 190 | 8 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | MED18 DMXL1 PNMA8B FAP C1QTNF7 NONO FAT3 DDI2 RBM39 TENM4 LRP1 CDH16 SENP7 | 9.37e-05 | 413 | 190 | 13 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | CADM4 COL6A5 KLF4 PLXNB2 PNMA8B IGSF10 NEO1 ALDH1A2 C1QTNF7 TEAD2 FAT4 FAT3 GRK5 RNF213 LBP TENM4 EGR2 LRP1 CDH12 | 1.03e-04 | 797 | 190 | 19 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 1.04e-04 | 161 | 190 | 8 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RGMB CEBPA FAP ALDH1A2 VPS13A FAT4 ANK3 FAT3 PCDHB7 PCDHB3 PCDHA11 LAMC1 TSPY26P TEAD1 TENM4 SETD5 PHF3 AGRN DCBLD2 | 1.19e-04 | 806 | 190 | 19 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.23e-04 | 165 | 190 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 1.28e-04 | 166 | 190 | 8 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | RGMB KIF26A FAT4 B4GALNT4 OGT ANK2 ANK3 FAT3 PCDHB7 PCDHA11 LAMC1 TEAD1 TENM4 SBNO1 SETD5 PHF3 ELAVL3 KIF13A AGRN | 1.44e-04 | 818 | 190 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | RGMB OGT ANK3 FAT3 LAMC1 TEAD1 TENM4 SBNO1 SETD5 PHF3 KIF13A AGRN | 1.91e-04 | 385 | 190 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.01e-04 | 225 | 190 | 9 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | MED18 DMXL1 PNMA8B ALDH1A2 C1QTNF7 NONO LTBP4 FAT3 DDI2 RBM39 CDH16 SENP7 | 2.42e-04 | 395 | 190 | 12 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | COL6A5 PLXNB2 PNMA8B IGSF10 NEO1 ALDH1A2 C1QTNF7 LTBP4 FAT4 FAT3 GRK5 RNF213 LBP TEAD3 TENM4 EGR2 LRP1 CDH12 | 3.04e-04 | 797 | 190 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | MED18 DMXL1 PNMA8B ALDH1A2 C1QTNF7 NONO LTBP4 FAT3 DDI2 RBM39 LRP1 CDH16 | 3.10e-04 | 406 | 190 | 12 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | RGMB FAP ALDH1A2 FAT4 ANK3 FAT3 PCDHA11 TEAD1 SETD5 PHF3 AGRN DCBLD2 | 3.24e-04 | 408 | 190 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | MED18 CENPE NHLRC2 DMXL1 PNMA8B YOD1 ALDH1A2 C1QTNF7 NONO RNF213 DDI2 ECT2 RBM39 TENM4 SPHKAP MORC3 CDH16 SENP7 | 3.37e-04 | 804 | 190 | 18 | gudmap_developingGonad_e12.5_ovary_1000 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ANKS1B PLCB1 C1QTNF7 LTBP4 ANK3 ADAMTSL3 TENM4 SPHKAP LRP1 LRP4 FRMD5 | 5.71e-10 | 185 | 193 | 11 | 3b2dfc8f4c87be516265dbecfc251276034d0efd |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-07 | 183 | 193 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-07 | 186 | 193 | 9 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-07 | 191 | 193 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-07 | 192 | 193 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-07 | 192 | 193 | 9 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-07 | 192 | 193 | 9 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-07 | 192 | 193 | 9 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-07 | 192 | 193 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-07 | 193 | 193 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-07 | 194 | 193 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-07 | 194 | 193 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.37e-07 | 200 | 193 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 160 | 193 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 160 | 193 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.57e-07 | 162 | 193 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 174 | 193 | 8 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 178 | 193 | 8 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| ToppCell | ASK452-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.18e-06 | 179 | 193 | 8 | c3cf49c069e66db16d2fce1de4c52a4c4fe7e832 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 183 | 193 | 8 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.45e-06 | 184 | 193 | 8 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 188 | 193 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 189 | 193 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-06 | 189 | 193 | 8 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 190 | 193 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 191 | 193 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-06 | 191 | 193 | 8 | c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.00e-06 | 192 | 193 | 8 | b86476037ddf8904c1d8a6b3763af7242c031cf3 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 192 | 193 | 8 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-06 | 192 | 193 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 192 | 193 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 192 | 193 | 8 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 193 | 193 | 8 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-06 | 193 | 193 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 193 | 193 | 8 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-06 | 194 | 193 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 2.16e-06 | 194 | 193 | 8 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 194 | 193 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-06 | 195 | 193 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.24e-06 | 195 | 193 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 196 | 193 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 196 | 193 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 196 | 193 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-06 | 199 | 193 | 8 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 199 | 193 | 8 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-06 | 199 | 193 | 8 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-06 | 199 | 193 | 8 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-06 | 199 | 193 | 8 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-06 | 199 | 193 | 8 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-06 | 199 | 193 | 8 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | control-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-06 | 200 | 193 | 8 | 251ca08fab5cc2a4e280db6a6286a9ebaef3e61a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-06 | 200 | 193 | 8 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.18e-06 | 166 | 193 | 7 | 68e6fc7c0040bbe48a93f96ecf28afffdc626845 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-06 | 170 | 193 | 7 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.92e-06 | 171 | 193 | 7 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | ASK452-Immune-B_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.11e-05 | 174 | 193 | 7 | 69723f5666abc3af5f0431901a60246c9915ef81 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 175 | 193 | 7 | 78a86cac3e6c0d115c997d1c29ee0e24af54551f | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 176 | 193 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 176 | 193 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-05 | 179 | 193 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 179 | 193 | 7 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 180 | 193 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 180 | 193 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.38e-05 | 180 | 193 | 7 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 181 | 193 | 7 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 1.43e-05 | 181 | 193 | 7 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-05 | 181 | 193 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 181 | 193 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 181 | 193 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 185 | 193 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-05 | 185 | 193 | 7 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.77e-05 | 187 | 193 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 187 | 193 | 7 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 189 | 193 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 189 | 193 | 7 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 189 | 193 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 189 | 193 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 190 | 193 | 7 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 190 | 193 | 7 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 191 | 193 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 191 | 193 | 7 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 191 | 193 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | facs-GAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 191 | 193 | 7 | 1f5d1e8c313a8dc83c06d2ee45f369b0ec507fbf | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 191 | 193 | 7 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-05 | 192 | 193 | 7 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.10e-05 | 192 | 193 | 7 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 2.10e-05 | 192 | 193 | 7 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 192 | 193 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 192 | 193 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | MED18 TNFRSF10C KLF4 HPS1 LTBP4 PTPRU SBNO2 ZNF34 ARRB2 KIF13A AGRN | 8.29e-07 | 194 | 192 | 11 | 4804_DN |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HG-U133A | PLXNB2 TXNL4A PLCG1 GRK5 DLGAP4 TEAD3 SBNO2 KPTN TTLL4 GEMIN4 | 6.77e-06 | 196 | 192 | 10 | 1923_UP |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | MED18 RAD54L2 FGFR1 PLCG1 LTBP4 PTPRU SBNO2 ZNF34 ARRB2 KIF13A | 7.40e-06 | 198 | 192 | 10 | 4805_DN |
| Drug | Cocaine | ANKS1B NCF2 KLF4 PLXNB2 GALNT16 PNMA8B NEO1 NFKB1 HPS1 PLCB1 FGFR1 PLCG1 NONO GRIK5 TEAD1 ATE1 APP TENM4 SBNO1 EGR2 LRRC27 GRIP2 TNFRSF1A TRIB1 ATP5F1A FRMD5 CDH16 | 1.66e-05 | 1314 | 192 | 27 | ctd:D003042 |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 2.41e-05 | 181 | 192 | 9 | 5963_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.68e-05 | 191 | 192 | 9 | 5210_DN | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 4.00e-05 | 193 | 192 | 9 | 2482_UP | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.00e-05 | 193 | 192 | 9 | 1051_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | 4.16e-05 | 194 | 192 | 9 | 1437_DN | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 192 | 9 | 2796_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 4.51e-05 | 196 | 192 | 9 | 4423_DN | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; HL60; HT_HG-U133A | 4.51e-05 | 196 | 192 | 9 | 2939_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 4.51e-05 | 196 | 192 | 9 | 6924_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 4.51e-05 | 196 | 192 | 9 | 6745_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.51e-05 | 196 | 192 | 9 | 7147_DN | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; HL60; HG-U133A | 4.69e-05 | 197 | 192 | 9 | 1992_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HG-U133A | 4.88e-05 | 198 | 192 | 9 | 1910_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.88e-05 | 198 | 192 | 9 | 6228_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.07e-05 | 199 | 192 | 9 | 5295_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.07e-05 | 199 | 192 | 9 | 4297_DN | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.27e-05 | 200 | 192 | 9 | 2648_UP | |
| Disease | late-onset Alzheimers disease | 2.73e-06 | 292 | 186 | 11 | EFO_1001870 | |
| Disease | lymphocyte count | MED18 CEBPA KIAA0232 CDH23 NHLRC2 PLXNB2 FAP ALDH1A2 NFKB1 PLCB1 C19orf44 C1QTNF7 PCDHGC4 PCDHGB6 GRK5 GRIK5 SBNO2 ARRB2 TENM4 SBNO1 EGR2 MORC3 TNFRSF1A PCDHGA8 TRIB1 | 5.94e-06 | 1464 | 186 | 25 | EFO_0004587 |
| Disease | Schizophrenia | DLGAP2 DLGAP1 LILRB1 ALDH1A2 PLCB1 FGFR1 ANK3 GPS1 GRIK5 ADNP ADAMTSL3 SBNO2 TENM4 SBNO1 EGR2 SAP30BP LRP1 TNFRSF1A | 1.33e-05 | 883 | 186 | 18 | C0036341 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 6.49e-05 | 157 | 186 | 7 | DOID:224 (biomarker_via_orthology) | |
| Disease | 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement | 6.73e-05 | 13 | 186 | 3 | EFO_0021053 | |
| Disease | infant head circumference | 1.06e-04 | 15 | 186 | 3 | EFO_0004577 | |
| Disease | colorectal cancer, inflammatory bowel disease | 2.22e-04 | 19 | 186 | 3 | EFO_0003767, MONDO_0005575 | |
| Disease | Premature aging syndrome | 2.35e-04 | 4 | 186 | 2 | C0231341 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.39e-04 | 257 | 186 | 8 | DOID:10652 (is_marker_for) | |
| Disease | lymphocyte percentage of leukocytes | CEBPA CDH23 VPS16 NFKB1 PLCB1 DTHD1 GRK5 SBNO2 ARRB2 SBNO1 PRKDC TNFRSF1A TRIB1 | 3.27e-04 | 665 | 186 | 13 | EFO_0007993 |
| Disease | kidney injury | 3.90e-04 | 5 | 186 | 2 | EFO_0009833 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.65e-04 | 57 | 186 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 6.19e-04 | 227 | 186 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 7.98e-04 | 29 | 186 | 3 | EFO_0008009 | |
| Disease | retinal detachment | 8.13e-04 | 7 | 186 | 2 | EFO_0005773 | |
| Disease | Bipolar Disorder | 9.47e-04 | 477 | 186 | 10 | C0005586 | |
| Disease | glycoprotein measurement | 9.64e-04 | 119 | 186 | 5 | EFO_0004555 | |
| Disease | blood nickel measurement | 1.00e-03 | 120 | 186 | 5 | EFO_0007583 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.07e-03 | 71 | 186 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 1.08e-03 | 8 | 186 | 2 | EFO_0801768 | |
| Disease | testosterone measurement | DLGAP1 CENPE ANKS1B NFKB1 PLCB1 FGFR1 PLCG1 USH2A ANK2 ANK3 NRDC DLGAP4 DNAH2 RIC8B EGR2 CTPS1 FRMD5 SOS1 | 1.23e-03 | 1275 | 186 | 18 | EFO_0004908 |
| Disease | visual epilepsy (implicated_via_orthology) | 1.28e-03 | 34 | 186 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | neuropsychological test | 1.61e-03 | 197 | 186 | 6 | EFO_0003926 | |
| Disease | Chlamydia trachomatis seropositivity | 1.72e-03 | 10 | 186 | 2 | EFO_0009330 | |
| Disease | neutrophil percentage of leukocytes | CEBPA CDH23 EMSY NFKB1 PLCB1 DTHD1 GRK5 SBNO1 PRKDC TNFRSF1A TRIB1 | 1.78e-03 | 610 | 186 | 11 | EFO_0007990 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.92e-03 | 139 | 186 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | 1-stearoyl-GPE (18:0) measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0800227 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0008209 | |
| Disease | Sclerocystic Ovaries | 2.24e-03 | 144 | 186 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 2.24e-03 | 144 | 186 | 5 | C0032460 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.50e-03 | 12 | 186 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.50e-03 | 12 | 186 | 2 | EFO_0008141 | |
| Disease | cardiac troponin T measurement | 2.74e-03 | 219 | 186 | 6 | EFO_0005043 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 2.77e-03 | 295 | 186 | 7 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Neurodevelopmental Disorders | 2.88e-03 | 93 | 186 | 4 | C1535926 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 2.88e-03 | 93 | 186 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | neutrophil count | NUP210L CDH23 NHLRC2 TNFRSF10C GALNT16 RRP12 PLCB1 DTHD1 PCDHA12 PCDHA11 PCDHA3 TEAD1 SBNO2 SBNO1 LRP4 PRKDC TRIB1 HYDIN | 2.94e-03 | 1382 | 186 | 18 | EFO_0004833 |
| Disease | Squamous cell carcinoma of esophagus | 3.11e-03 | 95 | 186 | 4 | C0279626 | |
| Disease | prostate cancer (is_marker_for) | 3.16e-03 | 156 | 186 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | TRIML1 ADAT3 ERCC6 LRRC37A2 GALNT16 EMSY LRRC37A PLCB1 FGFR1 DNAH9 ANK2 PCDHGB6 ECT2 SBNO1 EP300 | 3.45e-03 | 1074 | 186 | 15 | C0006142 |
| Disease | hearing impairment | 3.48e-03 | 98 | 186 | 4 | C1384666 | |
| Disease | low density lipoprotein triglyceride measurement | 3.93e-03 | 15 | 186 | 2 | EFO_0009946 | |
| Disease | response to olanzapine | 3.93e-03 | 15 | 186 | 2 | GO_0097333 | |
| Disease | Bell's palsy | 4.02e-03 | 102 | 186 | 4 | EFO_0007167 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.11e-03 | 51 | 186 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | cognitive function measurement | GALNT3 NUP210L PLXNB2 GALNT16 FAP PLCB1 USH2A CEP192 TEAD1 APP ADAMTSL3 NMD3 TENM4 PSMD14 CDH7 TRIM37 HYDIN SOS1 | 4.32e-03 | 1434 | 186 | 18 | EFO_0008354 |
| Disease | basophil count, eosinophil count | 4.37e-03 | 241 | 186 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 4.47e-03 | 16 | 186 | 2 | C0751885 | |
| Disease | focal segmental glomerulosclerosis | 4.47e-03 | 16 | 186 | 2 | EFO_0004236 | |
| Disease | 4-acetamidobutanoate measurement | 4.47e-03 | 16 | 186 | 2 | EFO_0021003 | |
| Disease | peanut allergy measurement | 4.47e-03 | 16 | 186 | 2 | EFO_0007017 | |
| Disease | basophil percentage of leukocytes | 4.55e-03 | 243 | 186 | 6 | EFO_0007992 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 5.05e-03 | 17 | 186 | 2 | C0751883 | |
| Disease | ischemia (implicated_via_orthology) | 5.05e-03 | 17 | 186 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | Fetal Alcohol Syndrome | 5.05e-03 | 17 | 186 | 2 | C0015923 | |
| Disease | clonal hematopoiesis mutation measurement | 5.08e-03 | 55 | 186 | 3 | EFO_0020949 | |
| Disease | mean platelet volume | NUP210L KIAA0232 RDH13 SEPTIN6 PLCB1 KCNS1 ACTL6B NCK2 PCDHGC4 NRDC PCDHGB6 GRK5 DNAJC5 PCDHGA8 | 5.42e-03 | 1020 | 186 | 14 | EFO_0004584 |
| Disease | alcohol consumption measurement | DLGAP2 KIF26A ANKS1B RBKS ADGRV1 PLCB1 XYLB DDX31 DNAH2 GRIK5 SPHKAP AGRN TRIB1 EP300 FRMD5 SENP7 | 5.52e-03 | 1242 | 186 | 16 | EFO_0007878 |
| Disease | C-X-C motif chemokine 16 measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0010911 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 5.90e-03 | 58 | 186 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | eosinophil count | MED18 CEBPA KIAA0232 TNFRSF10C EMSY FAP ALDH1A2 NFKB1 RRP12 LTBP4 NCK2 GRIK5 SBNO2 EGR2 PRKDC TNFRSF1A FUT5 TRIB1 | 6.28e-03 | 1488 | 186 | 18 | EFO_0004842 |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 6.30e-03 | 19 | 186 | 2 | C0751884 | |
| Disease | Hypertriglyceridemia | 6.30e-03 | 19 | 186 | 2 | EFO_0004211 | |
| Disease | glomerulonephritis (is_marker_for) | 6.30e-03 | 19 | 186 | 2 | DOID:2921 (is_marker_for) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 6.30e-03 | 19 | 186 | 2 | EFO_0802076 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSGDVELVLAYAAPV | 36 | Q96EY9 | |
| VTTYNLRDAPAESVA | 566 | Q9H2P0 | |
| VSQIDPSSIERAYAA | 456 | Q09472 | |
| LVYANDAAISEPESV | 241 | P12645 | |
| QPEEFVAIADYAATD | 31 | P55345 | |
| EEPNNLVDYSITHAE | 601 | Q96JP9 | |
| SLLYNVPAVAEEIQD | 546 | P05067 | |
| SPNIIFADADLDYAV | 291 | O94788 | |
| ASVLQVSDSPYDEQV | 261 | O94805 | |
| EQSDYVPVEFSLNDI | 51 | Q9BYG8 | |
| DNSPVFDQLSYEVTL | 991 | Q6V0I7 | |
| EATPAYSLVIQAVDS | 1276 | Q6V0I7 | |
| YTVQSSDSDLFVIDP | 3231 | Q6V0I7 | |
| EIEHYDIDNASSIAP | 4616 | Q6V0I7 | |
| YLNAVTESELANEIP | 1881 | O00468 | |
| PANVTAIVSLYGEDA | 61 | Q8WXG9 | |
| ESAESIEIYIPEAQT | 961 | O14490 | |
| ASERADSIEIYIPEA | 1036 | Q9P1A6 | |
| IFVYNLSPEADESVL | 286 | Q14576 | |
| DSPEIISELQQYADV | 1171 | Q9Y4B4 | |
| PEFNSSEYSVAITEL | 346 | Q9H251 | |
| IFLQSSYEASVPEDI | 1101 | Q9H251 | |
| DIYEAVSGDAVAVAP | 31 | Q8N7R7 | |
| VDVAFQDPSAVYSEL | 691 | Q9Y485 | |
| ESADSIEIYVPEAQT | 976 | Q9Y2H0 | |
| SPDYVLVEAEANRVA | 1276 | Q03468 | |
| DVPVDTNLIEFDTNY | 366 | P32121 | |
| ALPVIETQAGDVSAY | 366 | P25705 | |
| VSPIIDVISLDNFAY | 236 | Q8N428 | |
| LFAQEIEYSPVELES | 456 | Q9H4I0 | |
| IAYVEFVDVSSVPLA | 196 | Q14498 | |
| DNELVVRAYTPVSSD | 61 | Q6BCY4 | |
| APAQAQADSLTVYLV | 676 | Q9Y5E4 | |
| VDVSDITDPLQYFEL | 96 | Q96DM1 | |
| LSDNIYPVEDLAATS | 21 | P11161 | |
| ENLIYTADPESFEVN | 801 | Q9H8V3 | |
| DVFYEVSLDNNVEPA | 651 | Q9NYA3 | |
| EAVDPDVGVNSLQSY | 156 | Q9Y5G5 | |
| IVASDLEPLAVSSYV | 491 | Q9Y5F9 | |
| IAQIVASDPDFYSEA | 186 | Q5VVQ6 | |
| AIADLDPQFYTLSDV | 181 | Q9H477 | |
| SDLAENDEIYDPQIT | 2911 | Q01484 | |
| AAQDPEDLSTFAYIT | 1136 | Q7Z6G8 | |
| VTEQNEELSILYPAA | 201 | Q9H2M9 | |
| ASPEAALVDVNVYLI | 686 | Q9Y5I1 | |
| SSVVAETQRPYEEAL | 271 | Q9NUD7 | |
| QDAALAPEFLAVTEY | 101 | Q6N063 | |
| ATGPEAALVDVNVYL | 686 | Q9Y5H8 | |
| RPYDLAAATVATDLE | 61 | O43474 | |
| ELEPAQDSLVQSESY | 796 | O60309 | |
| ADIDYSLVEAPRATA | 226 | P18428 | |
| YQAPDIDVQLSSELT | 411 | Q9NZM5 | |
| PQYVSNELLEEAFSV | 156 | Q15233 | |
| ELEPAQDSLVQSESY | 796 | A6NM11 | |
| ELEPAQDSLVQSESY | 796 | A6NMS7 | |
| DLAVDSASPVYQAVI | 236 | O75112 | |
| TVVENATPDYAAGLV | 291 | Q9H3P2 | |
| QVEALFSYEATQPED | 461 | P19878 | |
| PSNYVLEEVDEAAAE | 161 | O43639 | |
| VPDIDNVTVLDYDAR | 1611 | Q07954 | |
| TYAPSVAEADVDVLL | 216 | Q92952 | |
| DDVEYAPLTVSVIVQ | 1456 | O15031 | |
| DSPVIQVLAYDADEG | 2601 | Q9NYQ8 | |
| VPRVSSNYVDEELLD | 746 | Q92628 | |
| FNYIPVDAEIVSIDT | 71 | Q9Y664 | |
| SAVAELIDNAYDPDV | 31 | Q14149 | |
| VVENPSLDLEQYAAS | 36 | Q13098 | |
| LDSTGVELVVNYDFP | 461 | Q9NUL7 | |
| ILLVNDTAAVAYDPT | 306 | O60662 | |
| PESAEYLAALERATA | 1831 | Q9ULI4 | |
| APAAASEAPQDVTYA | 541 | O75023 | |
| SLPEYQAREAAAAVA | 241 | Q96KK3 | |
| VLYVILAPFDNEQSD | 271 | O00232 | |
| LDVNDNAPYITVTSE | 341 | Q9Y5F7 | |
| ILAPSEAEYVNSLAS | 631 | Q9H8H2 | |
| TEFYVSPEDLEAQLQ | 146 | Q9H3Z4 | |
| NVAADIPITETEAYQ | 551 | Q2M2Z5 | |
| PAQTSLEYALLDAVT | 16 | Q8NBF2 | |
| VETSAYQVELELVPA | 176 | Q8N8X9 | |
| LAAQPSTYLAVAEEL | 266 | Q8NBN7 | |
| SYLVELSVVAPAGQD | 166 | Q9BUE0 | |
| EISYQSIESSDPAVN | 521 | Q92729 | |
| APAQAQADSLTVYLV | 676 | Q9Y5E5 | |
| AAPDQANSLTVYLVV | 676 | Q9Y5E2 | |
| VAVIADEAYSPADSV | 416 | Q7Z6J6 | |
| QDLEQSLAAAYVPVV | 51 | X6R8D5 | |
| SVIPTYRDQAAVIEA | 4021 | Q9C0G6 | |
| APDNVLEVTARAITY | 66 | Q9ULT8 | |
| YEAVVTAVDPVADIA | 216 | O43464 | |
| SPIAFTEENDYIVLN | 341 | Q6WRI0 | |
| LQYLEFSPIDSTVDV | 4251 | Q4G0P3 | |
| TLEYAPVDITVNLDA | 666 | Q92953 | |
| AAPHQAVAEIDALYD | 171 | Q92874 | |
| VEVQDSVPADSGLYA | 86 | P11362 | |
| SIDISAYIDPAAFND | 61 | P49715 | |
| VISADAIEALTAYSP | 571 | Q9H6X5 | |
| LARIAENYTAVVSPD | 291 | Q14435 | |
| ENYTAVVSPDIASID | 296 | Q14435 | |
| PTELVFALDNSYDVT | 1756 | A8TX70 | |
| DAEPGTLIYQVTAID | 2096 | Q8TDW7 | |
| LVVYDPGAVVEAQTS | 306 | Q8NFZ8 | |
| HNVPVDDVTNDYLTA | 356 | Q12955 | |
| EYLDVLSDVTGPQVS | 171 | Q6ZMT9 | |
| DQEVFVEVYNLTADP | 471 | P15586 | |
| EAAARAEAAAPYTVL | 256 | Q8N2S1 | |
| DPSEEAAVLQYASLV | 491 | O95260 | |
| APEENTAAIVYVENG | 836 | Q8TEP8 | |
| DVFYEVSLDNNVEPA | 651 | P0CG33 | |
| EIYASVAQLSPLDSE | 1266 | P11047 | |
| QQELYFLPVVIEDSS | 561 | P55289 | |
| SPSIAVVESELVAEY | 821 | Q7Z589 | |
| TTVLQADSAEYAQPL | 611 | Q96PD2 | |
| PDLYSDDEVENIISN | 2906 | Q9NYC9 | |
| SVVQVTATDADDPTY | 171 | Q9ULB5 | |
| LESGIPAAESQIVYA | 36 | Q5TDH0 | |
| VSLYPSNEDVSLAVS | 136 | Q16478 | |
| ALFQVEYDVATPDTV | 226 | Q9C0E4 | |
| IQFLDSVAEYEVTPD | 81 | P34947 | |
| VQDLYPSESTAEDDI | 241 | Q92902 | |
| QVPESSDSLFAYLIE | 2866 | Q9P225 | |
| QVTAPEYVFLISELA | 986 | A3KN83 | |
| ASGSTVIYLQPEDEV | 231 | Q9BXJ2 | |
| NVYEEIAAPIIDSAI | 61 | Q02224 | |
| NTPYVNEVSTDEALL | 331 | Q02224 | |
| LVTLDYIQFDTDTPA | 1516 | Q9C0B2 | |
| AQPGDTYTVLVEAQD | 626 | O75309 | |
| LVDDVTVVPENATIY | 896 | Q5VU65 | |
| YIITDQETSPAEVAE | 676 | O15294 | |
| EFAQPLYEVAVLENT | 241 | Q9Y5E6 | |
| AVDPEAALVDINVYL | 686 | Q9UN75 | |
| DAPAVDTAEQVYISS | 21 | O00487 | |
| PAQAQADSLTVYLVV | 676 | Q9Y5E3 | |
| IATISPAADNYEETL | 326 | Q9H1H9 | |
| ITADSSVYPQADAVI | 106 | Q11128 | |
| EYSTAVREAPAELAE | 356 | Q75VX8 | |
| FINAYLVDDSVSDTP | 276 | Q9NZJ7 | |
| PYQVAAEISQELAES | 181 | A2RTX5 | |
| AVEDQPDVSAVLSAY | 191 | Q15542 | |
| SEENYIVTDLAVFTP | 2101 | O75445 | |
| LSVETDYTFPLAENV | 251 | Q8NHW5 | |
| VYQAVTDDLPAAFVD | 231 | Q6NW40 | |
| LEEAVYEDFPQTVSQ | 871 | Q9BQF6 | |
| IPEEDSEARAYVNSL | 1086 | Q2M3C7 | |
| AQLYSVDVTLDPDTA | 311 | P14373 | |
| ELVPSYDSATFVLEN | 271 | O94972 | |
| APAVTTEAIYEEIDA | 451 | O75674 | |
| RDLVLPDVSYQVESS | 296 | Q8N6T0 | |
| NPVASDSYEAAVLSL | 481 | A6NFQ2 | |
| SYEVPSVAAADLEEG | 6 | Q9C0I9 | |
| TEAAASEAPQDVTYA | 601 | Q8NHL6 | |
| YLESVARVPAEDETQ | 211 | Q8WZ73 | |
| PLEEALNQYSVIEET | 501 | Q9NVN3 | |
| ELDNPEFVAIVAYTD | 326 | Q9ULN7 | |
| TDTSEVDLFVINAPY | 831 | Q92859 | |
| YIDSADLEPITSQEE | 336 | P17812 | |
| ESVEASPAVNEKSVY | 26 | Q9C0A6 | |
| QVSAPEYVFLISELA | 846 | Q9Y2G9 | |
| SPDIEQSFQEALAIY | 46 | Q15562 | |
| DQNPYTESVDILEDL | 46 | Q15543 | |
| PTLESNDDALQYVEE | 36 | Q07889 | |
| QIYQFPTDDESVAEI | 211 | Q14141 | |
| EAVESPESLAAVAYL | 156 | Q5JTH9 | |
| LQLPEAEAVDVTAQY | 711 | Q76KP1 | |
| DSARPVLLQVAESAY | 316 | Q9UJS0 | |
| NAHSLDPATLYEVEE | 1011 | Q96EP0 | |
| LAYAEFNDTDIPVIA | 221 | Q12884 | |
| SVPEILDTVSNVDYF | 341 | Q8IZ63 | |
| EPANEASVEYLQEVA | 4216 | Q63HN8 | |
| DTDYDVALVPESNVR | 276 | Q6PCB0 | |
| LEAVAATEEYPSVST | 996 | O95625 | |
| AEPLEIIYDARTVNS | 586 | Q96RL7 | |
| QIVPEYQEDSDISSF | 356 | Q96RU8 | |
| DPEEESLYQAIAVVT | 1006 | Q0IIM8 | |
| VADESLTDLEAQPYE | 191 | Q92791 | |
| SPDIEQSFQEALAIY | 36 | Q99594 | |
| PESIQFVLDEDSYLV | 296 | Q9H269 | |
| VLADVFDAPVYVIDT | 451 | O75191 | |
| VLAYSATTARQEEVP | 21 | O14798 | |
| ILTHNLAEPAYEADV | 731 | O43847 | |
| LIIDYLAEFNSTPAV | 776 | O43847 | |
| PVTEEDQISYTLLFA | 1276 | Q92576 | |
| AFVASEYPVILSIED | 401 | P19174 | |
| FVISVEQYPELSDSA | 2741 | Q6N022 | |
| NVLSSLAVYAEDSEP | 6 | Q9UHR5 | |
| DTYADVIEALSNPIR | 801 | Q9NQ66 | |
| ASVIDSAELQAYPAL | 3431 | P78527 | |
| TEITLDPATANAYLV | 286 | Q8N9V2 | |
| QLSVEPYSQEEAERA | 91 | O00488 | |
| AVIYLVDITEVPDFN | 56 | P83876 | |
| SPDIEQSFQEALAIY | 36 | P28347 | |
| LAEAVLTYLEPESAA | 186 | O60294 | |
| AEAVSAQADRAYLPL | 156 | Q9H489 | |
| DQDFYASVLDVLTPD | 991 | Q14679 | |
| LDTDDPATLYAVVEN | 351 | P19438 | |
| PQAEVTFEDVAVYLS | 31 | Q8IZ26 | |
| SDVESSSVLYAEAPV | 1271 | P82987 | |
| ALTEDDPQEVSATVY | 251 | P57678 | |
| VPELNNVISLDYDSV | 1381 | O75096 | |
| VNIYRDSAIPVESDT | 456 | Q96D46 | |
| YTEAIEVIQAASSPV | 881 | P19838 | |
| DVLQQDELDSYPDSV | 456 | Q9NQS3 |